Faeth Therapeutics, Inc. (FTH) stock

FTHNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30

$10.65−2.70 (-20.22%)

Close on Nov 12, 2026Market cap $275.20MP/E –Yield –

Faeth Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

Faeth Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?